Dr. Judy Chou @biologicsiscool to deliver a keynote titled “The Pursuit of Excellence in Innovative Biologics” at the 17th Annual Bio Innovation Leaders Summit, February 12th, in Singapore to discuss advanced technologies required in innovative biologics to truly benefit patients

Our President and CEO, Dr. Judy Chou (@biologicsiscool), joined @Xtalks Webinars to share her journey in biopharma and Altrubio’s vision. She discussed our first-in-class immune checkpoint enhancer & our ongoing trial in ulcerative colitis. Interview here: youtu.be/h_-K56JO7os

Our President & CEO, Dr. Judy Chou was recently interviewed by Edward Nash, Managing Director, Biotechnology Research at Canaccord Genuity to discuss AltruBio’s first-in-class PSGL-1 agonist antibody for immunological & inflammatory (I&I) diseases. Link: bit.ly/3C0Ci2L

Our President & CEO, Dr. Judy Chou will join a panel to discuss 'Aligning with Regulatory Authorities' during drug development at the @LongwoodLeaders #SanFranciscoCEO conference on January 12, 2025. More information here: bit.ly/3W4mPFP

We are pleased to announce our scientific advisory board, Vijay Kuchroo, DVM, PhD, Bernard Malissen, PhD, and Arlene Sharpe, MD, PhD, advancing novel immune checkpoint enhancer PSGL-1 agonist antibody, ALTB-268, in Phase 2a trials for #ulcerative colitis. bit.ly/3B1JCL8

Our leadership team had the pleasure of visiting the National Taiwan University, College of Medicine, a prestigious academic institute and alma mater to many of our team members. We are grateful for the long-term collaboration driving advancements in science.

Our leadership team had great discussions with the physician leaders at National Taiwan University Hospital, experts in #InflammatoryBowelDisease. United by a passion for science & a commitment to helping patients with immunological diseases, we’re grateful for this partnership.

Our President and CEO, Dr. Judy Chou and AltruBio’s Leadership Team visited the National Biotechnology Research Park (NBRP), a renowned institute focused on research and translational sciences for biomedical development in Taiwan. We look forward to future collaboration.

Our President and CEO Dr. Judy Chou is invited to the @APEC_CEOsummit 2024, Nov 13-15 in Lima, Peru. Bringing together CEOs, entrepreneurs, & thought leaders, the Summit provides a platform for exchanging ideas, collaboration & relationship building. Link: bit.ly/48IhMjn

We’re excited to share that AltruBio has been named a @BioSpace 2025 Best Places to Work honoree for the 3rd year in a row, recognized as one of the top 30 small biopharma employers based on votes from thousands of life science community members. Link: bit.ly/40J1FzX